Novo Nordisks New Weight-Loss Drug Getting a Boost From Pandemic: CEO

COPENHAGEN (Reuters) – The pandemic is pushing more people to seek treatment for obesity, Novo Nordisk’s top boss said on Thursday, referring to strong sales of the newly launched drug, Wegovy, which helped the drugmaker raise its earnings forecast for the full year. Sales of prescriptions drugs to treat obesity have failed to take off in the past due to […]
Continue reading »